W. Bradford Middlekauff, Senior VP, GC and Secretary at Edge Therapeutics, Inc. (EDGE), bought 9,857 shares at $9.48 ($93K) on 2016-08-05, disclosed to the SEC on 2016-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MEDX | SELL | 2006-03-17 | $1.4M | — | Filing → |